Future Directions in Managing KRAS-Mutant Advanced NSCLC

preview_player
Показать описание
Concluding their discussion on KRAS-mutant advanced non–small cell lung cancer, experts look toward the future treatment landscape.

  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Future Directions in 0:03:57

Future Directions in Managing KRAS-Mutant Advanced NSCLC

Impact of Coalterations 0:03:41

Impact of Coalterations on KRAS-Mutant NSCLC

Tailoring Targeted Therapy: 1:31:34

Tailoring Targeted Therapy: New Directions for Managing Patients Across the Spectrum of NSCLC

Current treatment strategies 0:01:10

Current treatment strategies KRASG12C–mutated NSCLC

KRAS G12C Inhibitors: 0:05:23

KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies

Daniel Ahn, D.O., 0:34:10

Daniel Ahn, D.O., M.S. discusses Targeting KRAS in Colorectal Cancer

Treatment Strategies for 0:05:06

Treatment Strategies for Left-Sided KRAS-Mutated CRC

Liquid biopsy: future 0:03:00

Liquid biopsy: future directions for ctDNA in NSCLC

Mutant p53 and 0:05:17

Mutant p53 and oncogenic KRAS drive metastasis in pancreatic cancer

Patient portals and 0:28:43

Patient portals and EHR portability: moving data with the patient - Gil Alterovitz

Future Directions for 0:39:01

Future Directions for Targeted Therapy - BRAF, NRAS, and more

Pancreatic Cancer: Current 1:01:08

Pancreatic Cancer: Current Challenges, Future Directions – Can we make the Impossible...Possible?

Dr. Skoulidis and 1:56:56

Dr. Skoulidis and Terri Conneran Discuss Treatment Strategy for Lung, Colon, and Pancreatic Cancers

Conclusion: Future Direction 0:04:50

Conclusion: Future Direction of Breast Cancer Treatment

Debate: Targeted therapy 0:17:17

Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory

Safety of sotorasib 0:07:19

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer

Advances in the 0:29:21

Advances in the Management of Cervical and Endometrial carcinoma

Immunotherapy for NSCLC: 0:07:32

Immunotherapy for NSCLC: Recent advances and future directions

CHIP & ICUS: 0:19:20

CHIP & ICUS: What do we know and what do we need to do?

Lung Cancer Overview 0:03:27

Lung Cancer Overview From ASCO - Future Directions

CMML: Risk Stratification 0:19:30

CMML: Risk Stratification and Treatment

Biomarkers for treatment 0:22:49

Biomarkers for treatment selection in colon cancer

Advancing Care for 0:53:55

Advancing Care for Patients With EGFR Mutation–Positive NSCLC: Precision Medicine Strategies

Optimizing outcomes in 0:04:56

Optimizing outcomes in EGFR mutation-positive NSCLC with TKIs